Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
  • Categories
  • Features
    • Category Blocks
    • Content Blocks
      • Accordions
      • Alerts
      • Author
      • Facebook Fanpage
      • Instagram Feed
      • Pinterest Board
      • Progress Bars
      • Separators
      • Share Buttons
      • Social Links
      • Subscription Forms
      • Tabs & Pills
      • Twitter Feed
    • Content Formatting
      • Badges
      • Drop Caps
      • Styled Blocks
      • Styled Lists
      • Numbered Headings
    • Gallery Blocks
    • Promo Blocks
    • Inline Posts
    • Contact Form
  • Sample Page
  • Buy Now

Categories

  • Alpha Lab
  • Candlestick Patterns
  • Chart Patterns
  • Crypto Currencies
  • Custom Indicators
  • Custom Strategies
  • Famous Traders
  • Futures Trading
  • ML And AI Models
  • Options Trading
  • Stocks and ETFs
  • Strategy Backtesting
  • Strategy Filters
  • Technical Indicators
  • Theme Investing
  • Trading Psychology
  • Trading Strategies
Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
Follow
Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
  • Home
  • About Us

Browsing Category

Stocks and ETFs

134 posts

Go beyond the ticker symbol. Here, we break down the mechanics of Stock and ETF trading, focusing on technical setups, sector rotation, and risk management. Discover how to pick high-momentum stocks and leverage thematic ETFs to capitalize on the 2026 market’s biggest trends. Turn market data into actionable trade ideas.

SStocks and ETFs
Read More
  • 6 minute read

Top Cardiovascular Health Stocks to Watch in the GLP-1 Era

  • byQuantStrategy.io Team
  • May 7, 2026
The landscape of medical investing has been fundamentally altered by the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists.…
TTrading Psychology
Read More
  • 6 minute read

Risk Management in Biotech: Navigating FDA Approval Cycles for Heart Meds

  • byQuantStrategy.io Team
  • May 7, 2026
Developing a successful cardiovascular therapy is arguably one of the most capital-intensive and high-risk endeavors in the pharmaceutical…
SStocks and ETFs
Read More
  • 6 minute read

Theme Investing: The Convergence of Metabolic Health and Cardiovascular Care

  • byQuantStrategy.io Team
  • May 6, 2026
The landscape of modern healthcare investing is undergoing a seismic shift as the boundaries between chronic disease categories…
MML And AI Models
Read More
  • 5 minute read

The Role of AI in Predicting Fitness Membership Churn Post-GLP-1

  • byQuantStrategy.io Team
  • May 6, 2026
As the fitness landscape undergoes a seismic shift driven by the pharmaceutical weight-loss boom, understanding The Role of…
SStocks and ETFs
Read More
  • 5 minute read

Top 5 Fitness ETFs to Watch as GLP-1 Adoption Scales Globally

  • byQuantStrategy.io Team
  • May 6, 2026
The global healthcare landscape is undergoing a seismic shift as glucagon-like peptide-1 (GLP-1) receptor agonists, originally designed for…
SStocks and ETFs
Read More
  • 6 minute read

Planet Fitness and the GLP-1 Thesis: Why Low-Cost Gyms Might Win Big

  • byQuantStrategy.io Team
  • May 6, 2026
The rise of weight loss medications like Ozempic, Wegovy, and Mounjaro has sparked a massive debate in the…
TTechnical Indicators
Read More
  • 6 minute read

Technical Analysis of Planet Fitness (PLNT) Stock in a New Healthcare Era

  • byQuantStrategy.io Team
  • May 6, 2026
The investment landscape for fitness stocks has undergone a seismic shift as weight loss medications like Ozempic and…
SStocks and ETFs
Read More
  • 8 minute read

Investing in the Future of Cardiovascular Health: GLP-1 Breakthroughs and the Downstream Cardiac Care Market

  • byQuantStrategy.io Team
  • May 5, 2026
The landscape of global healthcare is currently undergoing a seismic shift, driven by the unprecedented success of Glucagon-like…
SStocks and ETFs
Read More
  • 6 minute read

GLP-1 Impact on Food and Beverage Stocks: Navigating the Shift in Consumer Behavior

  • byQuantStrategy.io Team
  • May 5, 2026
The rise of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro is no longer just a pharmaceutical phenomenon;…
SStocks and ETFs
Read More
  • 8 minute read

The GLP-1 Revolution: Analyzing the Multi-Sector Impact on Healthcare, Food, and Medical Device Stocks

  • byQuantStrategy.io Team
  • May 5, 2026
The rise of Glucagon-like peptide-1 (GLP-1) receptor agonists represents more than just a medical breakthrough in treating type…
Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
Disclaimer | Blog | About | Pricing | Contact Us | Privacy | Terms
0
0
0
0
28
0
0